Transmedics Group Inc (TMDX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Transmedics Group Inc   (NASDAQ: TMDX)


Transmedics Group Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Transmedics Group Inc's ROI in the second quarter of 2026?
Transmedics Group Inc achieved a return on average invested assets (ROI) of 13.51 % in its second quarter of 2026, this is above TMDX's average return on investment of -16.83%.
Transmedics Group Inc invested over the 12 months ending in its second quarter of 2026 $1,137 million

ROI fell compared to the first quarter of 2026, despite the net income growth of 125.8% from the first quarter of 2026.

Within the Healthcare sector 79 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 410, from total ROI ranking in the first quarter of 2026 at 411.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 48.49 % 36.82 % 22.06 % 17.58 % 16 %
Y / Y Net Income Change TTM 114.25 % 251.23 % 717.86 % 459.2 % 487.68 %
Investment (TTM) in Millions 1,366 1,343 975 862 829
Return On Investment (TTM) 13.51 % 17.15 % 22.11 % 11.45 % 9.36 %
TMDX's Overall Ranking # 410 # 411 # 178 # 602 # 658
Seq. Investment Change TTM 13.4 % 16.45 % 7.41 % 4.68 % 4.48 %
Seq. Net Income Change TTM -10.7 % -9.65 % 107.37 % 28.05 % 46.4 %
Net Income (TTM) in Millions 154 172 190 92 72

TMDX Company Profile >> Back to TMDX Roi Comparisons >> See Annual TMDX Return On Investment



Return On Investment TMDX's Ranking
Within: No.
Industry # 20
Sector # 80
Overall # 410

Return On Investment Statistics
High Average Low
21.99 %
-16.83 %
-122.26 %
(Dec 31 2025)   (Mar 30 2019)



  News about Transmedics Group Inc Return on Investment ROI

Investigative Developments Surrounding TransMedics Group, Inc. Shareholders Encouraged to Pursue Legal Rights Followi...

February 7, 2025

In a significant development within the financial landscape, TransMedics Group, Inc. (NASDAQ: TMDX) finds itself under scrutiny amid allegations suggesting that the company has disseminated materially misleading business information to the investing public. The Rosen Law Firm, renowned for its global investor rights advocacy, is actively investigating potential securities claims on behalf of shareholders affected by these allegations.On February 7, 2025, the Rosen Law Firm reiterated its commitment to representing investors who have incurred losses due to claims that TransMedics has failed to provide accurate and truthful disclosures regarding its business operations and financial health. This announcement follows an earlier warning issued on January 25, 2025, which highlighted similar concerns regarding the integrity of information provided to stakeholders.





Financial Statements
Transmedics Group Inc's II. Quarter Investments $ 1,366 Millions TMDX's Balance sheet
Transmedics Group Inc's II. Quarter Income $ 17 Millions Quarterly TMDX's Income Statement
TMDX's Income by Division See TMDX's Income by Division


TMDX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 975 738 643 246 103
Y / Y Investment Growth 32.2 % 14.69 % 161.47 % 138.79 % -26.47 %
Net Income in Millions 190 35 -25 -36 -44
Y / Y Net Income Growth 436.58 % - - - -
Annual Return On Investment 19.51 % 4.81 % -3.89 % -14.72 % -42.91 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 19.51 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TMDX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TMDX's Competitors
Subscribers only: Roi for Transmedics Group Inc's Suppliers
Subscribers only: Return On Investment for TMDX's Customers

Other Ratios
TMDX's Roa TMDX's Inventory Turnover Ratio TMDX's Growth Rates TMDX's Dividend Statistics
TMDX's Profitability Ratios TMDX's Asset Turnover Ratio TMDX's Dividend Growth
TMDX's Roe TMDX's Valuation Ratios TMDX's Financial Strength Ratios TMDX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %

Date modified: 2026-09-26T07:36:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.